Home › Pharmacology › Antidiabetic Agents

Antidiabetic Agents

Q: Which specific drugs belong to sulfonylureas?

Sulfonylureas include first- and second-generation drugs. First-generation drugs — carbutamide, tolazamide, tolbutamide, chlorpropamide.Second-generation drugs — glyburide (glibenclamide), gliclazide, glipizide, gliquidone.

Q: What drugs are classified as glucagon-like peptide-1 (GLP-1) analogs?

Glucagon-like peptide-1 (GLP-1) analogs include exenatide. Exenatide — an incretin mimetic targeting the surface membrane GLP-1 receptor. Activation of this receptor stimulates adenylate cyclase and triggers a cascade involving protein kinases, leading to the closure of ATP-sensitive potassium channels, membrane depolarization, and direct stimulation of insulin granule exocytosis.

Medicamenta antidiabetica

For medical students2 min readUpdated 2026-10-10

Antidiabetic agents are divided into two main groups: insulin preparations for replacement therapy and synthetic oral agents. They regulate glucose levels primarily by stimulating insulin secretion.

Main groupsInsulin preparations and synthetic oral agents

Sulfonylurea targetATP-sensitive potassium channel on the beta-cell membrane

Incretin mimeticsGlucagon-like peptide-1 (GLP-1) receptor agonists

GLP-1 mechanismActivation of adenylate cyclase and closure of potassium channels

Classification of Antidiabetic Agents

Pharmacological regulation of carbohydrate metabolism relies on two major categories of medications. Insulin preparations are used as replacement therapy. The second group consists of synthetic antidiabetic agents designed for oral administration. They differ in their mechanisms of stimulating hormone production.

Sulfonylureas and Meglitinides

This group of drugs stimulates insulin secretion through a direct effect on ion channels. Sulfonylureas and meglitinides (such as nateglinide) target the ATP-sensitive $K^+$ channel located on the $eta$-cell membrane.

The drugs bind to channel receptors and forcibly block them, mimicking the action of ATP.
This results in membrane depolarization and the opening of voltage-gated $Ca^{2+}$ channels, which triggers insulin secretion.
Key feature: This process occurs independently of glucose concentration and its metabolism, bypassing the ATP production step.

Incretin Mimetics and Receptor Pathways

An alternative method of stimulating secretion is achieved via receptor-mediated pathways using incretin mimetics. These include glucagon-like peptide-1 (GLP-1) receptor agonists (e.g., exenatide). Their site of action is the surface membrane GLP-1 receptor.

The intracellular cascade involves the following steps:

Receptor activation stimulates the enzyme adenylate cyclase (AC).
AC triggers a cascade of reactions involving protein kinases (PK pathway).
Kinases ensure the phosphorylation and closure of ATP-sensitive $K^+$ channels, maintaining depolarization.
Direct stimulation of exocytosis and release of insulin granules occurs.

The ultimate result of this cascade is the enhancement of glucose-dependent insulin secretion.

Mnemonic

Sulfonylureas 'force-close' potassium channels independently of glucose, whereas incretins act via receptors and adenylate cyclase more subtly — in a glucose-dependent manner.

Frequently asked questions

Which specific drugs belong to sulfonylureas?

Sulfonylureas include first- and second-generation drugs.

First-generation drugs — carbutamide, tolazamide, tolbutamide, chlorpropamide.
Second-generation drugs — glyburide (glibenclamide), gliclazide, glipizide, gliquidone.

What drugs belong to the meglitinide group?

Meglitinides, which act as prandial glucose regulators, include:

Nateglinide — a phenylalanine derivative that selectively blocks ATP-sensitive potassium channels of pancreatic beta-cells.
Repaglinide — a drug for controlling postprandial hyperglycemia with a rapid onset of action, suitable for patients with irregular meal schedules.

What drugs are classified as glucagon-like peptide-1 (GLP-1) analogs?

Glucagon-like peptide-1 (GLP-1) analogs include exenatide.

Exenatide — an incretin mimetic targeting the surface membrane GLP-1 receptor. Activation of this receptor stimulates adenylate cyclase and triggers a cascade involving protein kinases, leading to the closure of ATP-sensitive potassium channels, membrane depolarization, and direct stimulation of insulin granule exocytosis.

Which classes of oral antidiabetic agents improve tissue sensitivity to insulin?

Two classes of oral antidiabetic agents reduce insulin resistance and increase tissue sensitivity to insulin:

Biguanides (primary representative is metformin) — reduce insulin resistance in muscle and adipose tissue as well as hepatic glucose production.
Thiazolidinediones — insulin sensitizers that decrease insulin resistance in muscle and adipose tissue and hepatic glucose production.

What are the two main groups of antidiabetic agents?

Insulin preparations for replacement therapy and synthetic oral antidiabetic agents.

What is the site of action for sulfonylureas?

They act on the ATP-sensitive potassium channel on the beta-cell membrane, forcibly closing it.

What is the key difference in action between incretin mimetics and sulfonylureas?

Incretin mimetics enhance glucose-dependent insulin secretion via receptor apparatus and the adenylate cyclase pathway, whereas sulfonylureas work independently of the glucose level.

Go deeper

The role of ATP-sensitive potassium channels in regulating beta-cell membrane potential
Comparison of mechanisms of action between sulfonylureas and nateglinide
The role of adenylate cyclase and protein kinases in the incretin cascade
Mechanisms of insulin granule exocytosis during calcium potentiation
Differences between glucose-dependent and glucose-independent stimulation of insulin secretion